Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell

In this article, we will take a detailed look at Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell.

Jim Cramer is exuberant about the Federal Reserve’s aggressive rate cut.

“Believe me, there are few things more friendly than a 50 basis point rate cut,” Cramer said in a recent program.

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to recession-proof stocks that can produce consistent earnings despite market slowdowns.

“Once the Fed is done tightening and we start seeing signs of impending rate cuts you need to load up on the cyclicals, the companies that see massive earnings growth when the economy accelerates,” Cramer reminded his viewers about his advice on how to play the interest-rate game.

Jim Cramer has been talking about all sorts of stocks during his latest programs. In this article we picked 9 important stocks he’s bearish/bullish on and analyzed these companies in detail. With each stock we have mentioned its hedge fund sentiment. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

9. Gentex Corp (NASDAQ:GNTX)

Number of Hedge Fund Investors: 26

Talking about Gentex Corp (NASDAQ:GNTX), Cramer said the stock will be negatively impacted because it’s related to the auto industry.

“I don’t see a quick turn. We will need several Fed rate cuts before they turn, I am sorry.”

Gentex Corp (NASDAQ:GNTX) makes automatic-dimming rear-view mirrors and camera-based driver assistance systems for cars.

8. Celsius Holdings, Inc. (NASDAQ:CELH)

Number of Hedge Fund Investors: 27

Jim Cramer said in a latest program on CNBC that something is wrong with Celsius Holdings, Inc. (NASDAQ:CELH).

“The stock was at $99, and now it’s at $34 and we have not word from John Fieldy (company CEO) other than everything is great. That’s no longer tolerable for me. I want to know what’s wrong.”

Celsius Holdings, Inc. (NASDAQ:CELH) is down 47% so far this year. The energy drinks company is facing headwinds amid rising U.S. CPI for nonalcoholic beverages, exacerbated by the company’s price hikes in 2021 and 2022. These increases were implemented to address supply chain challenges, but they’ve led to higher prices, contributing to a shift in consumer behavior. More customers are opting for grocery mass online purchasing instead of convenience stores because of high prices.

With a 12-pack of Celsius Holdings, Inc. (NASDAQ:CELH) priced at around $21—nearly three times that of Coca-Cola—it’s not surprising that premium pricing could dampen demand further. The company’s U.S. sales growth may continue to slow, especially when compared to its impressive pre-pandemic 2-year compound annual growth rate (CAGR) of 44.2% and pandemic 4-year CAGR of 104.6%.

On the upside, Celsius Holdings, Inc. (NASDAQ:CELH) posted strong bottom-line growth in Q2 2024, with gross profit margins improving to 52% and adjusted EBITDA margins at 24.9%. However, there’s uncertainty surrounding how sustainable these margins will be as the company plans to ramp up promotional spending and marketing investments in the second half of 2024, which could pressure profit margins in the near term.

Alger Small Cap Growth Fund stated the following regarding Celsius Holdings, Inc. (NASDAQ:CELH) in its Q2 2024 investor letter:

“Celsius Holdings, Inc. (NASDAQ:CELH) engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. During the quarter, shares detracted from performance after the company reported fiscal first quarter revenues below analyst estimates. The revenue shortfall was attributed to ongoing inventory management challenges with PepsiCo, which decelerated year-over-year revenue growth from over 100% to approximately 37%. Despite the near-term growth slowdown, we believe Celsius remains well positioned to potentially capture market share within the large energy and soft drink industry over the long-term.”

7. Equity Residential (NYSE:EQR)

Number of Hedge Fund Investors: 30

Jim Cramer was asked about  Equity Residential (NYSE:EQR) in a latest program. He called the stock a “total winner.”

“That is just an amazing stock.It still got about a 3% yield you can still make money in it.”

Cramer said a shortage of housing and apartment complexes could create a further runaway for this stock, which is already up 20% so far this year.

Equity Residential (NYSE:EQR) owns about 79,738 apartments across major U.S. cities like Boston, New York, and San Francisco. The REIT focuses on high-end tenants in urban areas, primarily managing mid-and high-rise apartments, along with a number of garden-style units.

Bank of America Securities recently downgraded the stock to Neutral from Buy on concerns that a softening U.S. labor market may negatively impact its portfolio. Equity Residential (NYSE:EQR) urban demographic is seen as more vulnerable to potential economic slowdowns.

Equity Residential (EQR) has seen a slowdown in its growth metrics over recent quarters. Same-store rental income increased from $697.8 million in Q2 2023 (a 5.5% year-over-year growth) to $718.2 million in Q2 2024, but the growth rate dropped to 2.9%. Similarly, same-store net operating income (NOI) growth decelerated from 5.6% in Q2 2023 to 3.0% in Q2 2024. Despite this, the REIT provided positive guidance, raising expectations for same-store rental income by 70 basis points and NOI by 145 basis points. Additionally, expense guidance was reduced by 100 basis points, situating expected NOI growth at 3.25%, slightly higher than the latest YoY growth.

Baron Real Estate Fund stated the following regarding Equity Residential (NYSE:EQR) in its Q2 2024 investor letter:

“In the second quarter, the shares of Equity Residential (NYSE:EQR), the largest U.S. multi-family REIT, appreciated due to continued strong operating updates, an improved full-year growth outlook, and faster-than-expected improvement in the company’s West Coast markets. Management has assembled an excellent portfolio of Class A apartment buildings located in high barrier-to-entry coastal markets with favorable long-term demographic trends and muted overall supply growth. Please see the “Top net purchases” for further thoughts on the company.

In the second quarter, we increased the Fund’s REIT exposure to best-in-class multi-family owners/operators Equity Residential and AvalonBay Communities, Inc. Our meetings with each management team supported our view that both companies are led by astute executives that are highly focused on driving value creation for shareholders…” (Click here to read the full text)

6. Moderna Inc (NASDAQ:MRNA)

Number of Hedge Fund Investors: 39

When asked about Moderna Inc (NASDAQ:MRNA) in a latest program, Cramer said:

“Moderna has been a big disappointment.”

Moderna Inc (NASDAQ:MRNA) has been getting tarnished amid downgrades from Wall Street. It was one of the most shorted stocks in August. Investors are looking for growth catalysts for the stock beyond COVID.

The company recently cut its R&D budget by $1.1 billion between 2024 and 2027. The cancellation of five pipeline programs also signaled reduced confidence in its COVID-19 vaccine revenue or the potential of the shelved projects.

Moderna Inc (NASDAQ:MRNA) late-stage pipeline also faces significant challenges. The combined flu-COVID vaccine, expected to be filed for FDA approval soon, is entering a competitive field. Novavax and Sanofi are developing a similar shot, with trials expected to yield results by mid-2025. Moderna’s RSV vaccine, approved for adults 60 and over, also faces competition from GSK’s Arexvy, which holds a first-mover advantage in a key demographic (ages 50-59).

The company’s mRNA vaccines are also expected to face headwinds amid a wider reluctance in the public. A recent survey showed that only 43% of Americans plan to get the updated COVID-19 vaccine this year. Concerns over side effects, such as myocarditis and Guillain-Barré syndrome, linked to mRNA vaccines, continue to affect vaccine uptake.

Moderna Inc (NASDAQ:MRNA) projected 2025 revenue is $2.5 billion to $3.5 billion, giving it a high forward price-to-sales ratio of 10.2 times, well above the industry average of 3.8 times.

5. Nextracker Inc. (NASDAQ:NXT)

Number of Hedge Fund Investors: 39

Jim Cramer was recently asked about First Solar. He instead pitched Nextracker Inc. (NXT).

“I know it’s been a big disappointment for Club members but you got to stick with Shugar (company CEO).”

Earlier this year, Jim Cramer had said the following about NXT:

“Their technology lets you increase your yield from solar panels. The stock is down. It’s a great opportunity.”

Wall Street is also growing bullish on Nextracker Inc. (NASDAQ:NXT). Earlier this year, Mizuho gave a $59 price target on the stock, saying Nextracker Inc. (NASDAQ:NXT) is positioned to benefit from the demand growth of solar power driven by data centers and AI.

Nextracker Inc. (NASDAQ:NXT) stands to benefit from the secular tailwinds in the industry. According to data from the U.S. Energy Information Administration, solar is expected to grow at a CAGR of 26% over the next five years.

4. Viking Holdings Ltd (NYSE:VIK)

Number of Hedge Fund Investors: 41

Experiential travel and cruise company Viking Holdings Ltd (NYSE:VIK) is one of the stocks Jim Cramer is recommending. When a caller asked him about the stock in a latest program, he said:

“This is a really fine company and will do well for multiple years because they have many ships coming in. Buy Viking.”

Viking Holdings Ltd (NYSE:VIK) operates about 85 vessels and offers unique cruise experiences on major rivers, such as in Europe and the Mississippi, alongside global ocean and expedition voyages. Its primary revenue sources are cruise and land (93%) and onboard & other (7%).

VIK’s demand strength stands out within the travel and leisure industry, driven by both capacity expansion and favorable pricing. In the second quarter, the company saw a 9.1% year-over-year revenue growth, supported by a 6.6% increase in net yields (cruise revenue per passenger cruise day) and an occupancy rate of 94.3%, indicating strong demand despite growing capacity.

Relative to its competitors, such as Norwegian Cruise Line Holdings (NCLH), Royal Caribbean (RCL), and Carnival Corporation (CCL), Viking Holdings Ltd (NYSE:VIK) is expected to grow faster, with a projected growth rate of ~14% over the next 24 months. In comparison, RCL is expected to grow at ~11%, NCLH at ~9%, and CCL at ~7%.

All of this justifies the company’s forward EBITDA multiple of 10.6x, compared to 8.9x for its competitors.

3. Pfizer Inc (NYSE:PFE)

Number of Hedge Fund Investors: 84

Jim Cramer in a latest program on CNBC said that he “likes” Pfizer Inc (NYSE:PFE) at the current levels and the company’s 5.6% dividend yield.

Cramer also said he likes Pfizer’s “cancer strategy.”

Pfizer Inc (NYSE:PFE) is down about 3% so far this year as the market is still reluctant about the company’s path forward beyond its COVID revenues. However, the bulls believe there are plenty of growth catalysts for the company.

Its $43 billion acquisition of Seagen will play a key role in its oncology portfolio. Pfizer Inc (NYSE:PFE) potential success with antibody-drug conjugates (ADCs) is also worth watching, as these treatments could boost its oncology division’s performance. In the second quarter, Pfizer’s oncology revenue jumped 27% year-over-year, highlighting solid execution in this growth area.

What about the weight loss industry? Pfizer Inc (NYSE:PFE) is a clear laggard in this area when compared to rockstars like Eli Lilly and Novo Nordisk. However, the company plans to position its product Danuglipron competitively, with a large-scale phase III trial in the works.

Pfizer Inc (NYSE:PFE) is also focusing on cost-cutting efforts, targeting over $4 billion in savings. Additionally, its manufacturing optimization plans could reduce operating expenses by another $1.5 billion by 2027.

PFE’s forward adjusted PEG ratio of 1.16, about 40% below the industry median. Based on the above-mentioned catalysts, the stock could be a promising buy for long-term investors.

Parnassus Value Equity Fund stated the following regarding Pfizer Inc. (NYSE:PFE) in its first quarter 2024 investor letter:

“During the quarter, we added new positions in Pfizer Inc. (NYSE:PFE), NICE and Charter Communications. We purchased Pfizer to capture the potential upside from any turnaround following the COVID-induced boom-bust cycle of the last few years. Pfizer’s stock price sank by more than 40% in 2023 as COVID-19 vaccine revenues rolled off, providing an attractive entry point for us. The company completed its acquisition of Seagen, which should strengthen Pfizer’s pipeline in antibody-drug conjugates (ADC). Pfizer also offers an attractive dividend yield.”

2. Vertiv Holdings Co (NYSE:VRT)

Number of Hedge Fund Investors: 92

Jim Cramer in a latest program agreed with a caller who asked him whether he’d buy more Vertiv Holdings Co (NYSE:VRT) shares on a pullback.

“On a pullback, absolutely. Vertiv is a premier data center stock.”

Cramer said Vertiv is a “winner.”

Vertiv Holdings Co (NYSE:VRT) is a market leader in the data center power and cooling market, which has nowhere to go but up from here since companies are hungry for data center solutions as they begin to deploy AI software.

Vertiv Holdings Co (NYSE:VRT) is forming long-term partnerships with Intel and Nvidia to develop tailored solutions for their products. This is especially notable because AI training requires significantly more electricity and produces more heat than traditional servers, driving demand for specialized systems that Vertiv Holdings Co (NYSE:VRT) provides. The company estimates that the additional demand from AI could boost its top-line growth by up to 4% annually.

By designing products specifically for Nvidia’s GPUs, Vertiv can tap into Nvidia’s growth with minimal effort, as their systems are crucial for optimizing GPU performance. If Nvidia powers data centers with its processors, Vertiv provides the infrastructure that keeps them running efficiently.

Vertiv Holdings Co (NYSE:VRT) revenue has grown on average at 10% in the most recent quarters. The company has a backlog of over $7 billion, more than a year’s worth of current revenue. Vertiv is targeting a 20% operating margin by 2028.

Baron Small Cap Fund stated the following regarding Vertiv Holdings Co (NYSE:VRT) in its Q2 2024 investor letter:

“Vertiv Holdings Co (NYSE:VRT) a leading provider of critical digital infrastructure for data centers, contributed during the quarter. As an industry leader in data center cooling and power management, Vertiv is poised to benefit from AI-driven growth in data center spend. The NVIDIA partner network, strong industry relationships, and broad product portfolio that Vertiv maintains enables its participation in the creation of the technology roadmap for the future of the data center. In addition, Vertiv is investing in its capacity to serve this growing end market more effectively. The company also has an extensive global service network to aid customers as they grow. We believe the company has durable competitive advantages and a flexible balance sheet to benefit from the expected significant capital investment in data centers for years to come. Vertiv reported very strong results for the March quarter, with orders up 60%, which highlighted the strong demand it is seeing for its products. We sold some of our position into strength after the runup from the positive report, but still hold a major position in the Fund as we see considerable upside in the shares over time.”

1. Walt Disney Co (NYSE:DIS)

Number of Hedge Fund Investors: 92

Jim Cramer was recently asked about the amusement resort company Six Flags. He said he does not like the stock and instead recommended Walt Disney Co (NYSE:DIS) in this theme.

“I actually prefer, I am not kidding, I am not joking around, I actually prefer the stock of Disney,” Cramer added.

Walt Disney Co (NYSE:DIS) bulls believe the turnaround plan of CEO Bob Iger would work, it just needs more time. With interest rates now on the decline along with inflation, the company’s theme park business can see growth as consumers begin to increase spending.

Despite the inflation storm that affected Walt Disney Co (NYSE:DIS) Experiences business,  the segment has maintained a stable operating margin of 29% over the first nine months of the year, though this dipped to 26% last quarter.

Walt Disney Co (NYSE:DIS) in Q3 beat estimates and raised its outlook, as the performance was driven by a profitable streaming business. CEO Bob Iger’s leadership, combined with a $60 billion investment in parks and cruises, is expected to drive future growth.

Meridian Hedged Equity Fund stated the following regarding The Walt Disney Company (NYSE:DIS) in its Q2 2024 investor letter:

The Walt Disney Company (NYSE:DIS) operates a diversified entertainment business with theme parks, media networks, and streaming services. We own Disney because we believe its strong brand, valuable IP, and expanding streaming offerings will drive sustainable long-term growth. The company’s stock, however, underperformed in the quarter due to concerns about a slowdown in growth at its theme park division. While park revenue still grew by 10% year-over-year, management’s commentary suggested a moderation in post-pandemic demand and rising costs, leading to a disappointing outlook for park operating income in the second half of the year. This overshadowed the positive news that the company’s streaming segment, driven by strong subscriber growth at Disney+, reached profitability ahead of schedule. We held our position and will continue to monitor the performance of the theme park division.”

While we acknowledge the potential of The Walt Disney Company (NYSE:DIS), our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than DIS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and Jim Cramer is Recommending These 10 Stocks in June.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 8 Best TSX Stocks To Invest In Now and the 10 Worst Affordable Stocks Under $10.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.